Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

481
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
481

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival Outcomes in Middle-Aged and Older Patients With Advanced Heart Failure: A Propensity-Matched Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry.

JACC. Heart failure·2026
Same author

Double jeopardy: The plight of the durable LVAD patient waiting for heart transplant in the United States.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Early right ventricular failure following HeartMate 3 left ventricular assist device implantation: Risk factors and outcomes.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Net Prolongation of Life in Advanced Heart Failure: An Intentional Strategy of Durable LVAD Therapy Followed by Heart Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Endothelial CYB5R3 couples store-operated calcium entry to TRPV2 activation and vascular fitness.

bioRxiv : the preprint server for biology·2025
Same author

Toxicological seizures: characteristics, outcomes and recurrence.

Clinical toxicology (Philadelphia, Pa.)·2025

Related Experiment Video

Updated: Dec 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Predicting Survival After Extracorporeal Membrane Oxygenation by Using Machine Learning.

Brian Ayers1, Katherine Wood1, Igor Gosev1

  • 1Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, New York.

The Annals of Thoracic Surgery
|May 27, 2020
PubMed
Summary

Machine learning accurately predicts survival for patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO), outperforming existing scores. This AI tool can improve clinical decisions for VA-ECMO patients.

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

653
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K

Related Experiment Videos

Last Updated: Dec 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

653
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Medicine
  • Critical Care Medicine

Background:

  • Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is life-saving but linked to significant patient morbidity and mortality.
  • Clinical decision-making for VA-ECMO patients requires enhanced support tools.
  • High resource utilization necessitates improved patient management strategies.

Purpose of the Study:

  • To develop a machine learning (ML) algorithm for augmenting clinical decision-making in VA-ECMO patients.
  • To predict survival to discharge using initial laboratory values during VA-ECMO support.
  • To compare the ML model's performance against the established SAVE score.

Main Methods:

  • Retrospective review of 282 adult patients undergoing VA-ECMO from May 2011 to October 2018.
  • Utilized laboratory values from the initial 48 hours of VA-ECMO support.
  • Trained a deep neural network on 70% of data, validated on 15%, and tested on 15%, comparing AUC with the SAVE score.

Main Results:

  • The ML model achieved 82% accuracy in predicting survival to discharge in the testing cohort.
  • Key predictors identified included lactate, age, total bilirubin, and creatinine.
  • The ML model demonstrated a significantly higher area under the curve (0.92) compared to the SAVE score (0.65; P = .01).

Conclusions:

  • Machine learning models show potential to enhance clinical decision-making for VA-ECMO patients.
  • This proof-of-concept study highlights the utility of AI in critical care settings.
  • Further validation using multi-institutional data is recommended for broader applicability.